Introduction: Our group has published extensively on firefighters who were exposed to World Trade Center dust on 9/11/2001. Approximately 9000 firefighters have had serum drawn immediately post 9/11 as part of the World Trade Center (WTQ Medical Monitoring and Treatment Program (MMTP), and followed longitudinally. Many of these individuals developed cough, and pulmonary disease, and were treated with bronchodilators. The cohort continued to develop exposure-related diseases, including GERD and Barrett's, a pre-neoplastic manifestation. Since the use of beta-agonists can confound the developement of GERD in those with lung disease it was also quantified. This study focuses on predictive serum biomarkers of GERD and Barrett's. We also investigate the relationship between GERD/Barrett's and lung disease. Methods: Electronic medical records were used to identify those with incident GERD, Barrett's and of short-acting and long-acting beta-agonists (SABA and LABA) use in a population of never smokers with pulmonary complaints. Serum was analyzed on a subpopulation (N=327) representative of the cohort stratified on BMI and lung function using Luminex for 131 analytes. Pearson Chi-square test was used to determine associations between SABA/LABA use and aerodigestive disease. Multinomial regression was used to identify analytes that could predict GERD and/or Barrett's compared to controls without GERD/Barrett's, taking age, BMI, and exposure intensity into account. Results: Lung function (FEV 1) at the time of presentation to subspecialty pulmonary evaluation was no different in those with GERO or Barrett's compared to controls. SABAs was significantly associated with GERD, but not Barrett's (Pearson's Chi-square). In a multinomial regression adjusted for age, BMI, and exposure, SABA use was not a significant predictor. C-peptide and Insulin predicted GERD as continuous variables. CRP, Fractalkine, G-CSF, Insulin, IP-10, and Triglyceride significantly predicted Barrett's. Cutpoints were optimized in this population to determine clinically useful levels. ORs are shown in Figure 1 with 95% Confidence intervals. Conclusion: Similar to other studies, our population shows that there is an association between SABA use and GERD. However, there is no increased incidence of Barrett's associated with SABA use. We demonstrated that the metabolically active mediators, insulin and triglycerides, have a strong association with GERD and Barrett's. This pilot study frames future studies to further our understanding of aerodigestive pathology due to particulate exposure.
Keywords
Biomarkers; Fire fighters; Exposure levels; Risk factors; Dusts; Dust exposure; World Trade Center; WTC; Monitoring systems; Treatment; Pulmonary function; Pulmonary system; Pulmonary system disorders; Diseases; GERD; Gastroesophageal reflux disease; Lung; Lung function; BMI; Body Mass Index
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.